CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- CT ORDER Other Confidential Order
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale President & CEO sold 5,491 shares at an average $1.13 ($6,190)
Page 17 of 61 · 1,213 filings